Literature DB >> 29491487

Prevalence of reticular pseudodrusen in an elderly UK Caucasian population-The Bridlington Eye Assessment Project (BEAP): a cross-sectional study (2002-2006).

Craig Wilde1, Ali Poostchi1, Rajnikant L Mehta2, Jonathan G Hillman3, Hamish K MacNab3, Marco Messina1, Marco Morales1, Stephen A Vernon4, Winfried M Amoaku5.   

Abstract

AIMS: To determine prevalence, associations, and risk factors for reticular pseudodrusen (RPD) in a UK population.
METHODS: Cross-sectional study of Bridlington residents aged ≥65 years. Masked grading of colour fundus photographs from 3549 participants. RPD presence, phenotype, and topography were recorded, demographic details were analysed, and prevalence was calculated.
RESULTS: RPD was detected in 281 eyes (176 individuals) of 3476 participants (5.06%) with gradable images, and bilateral in 76.6%. Digital enhancement increased detection by 15.7%. Prevalence increased significantly with age from 1.18% (65-69 years) to 27.27% (≥90 years) (mean age 81.1, SD 6.01; OR 1.18, 95% CI 1.15-1.21, p value <0.001), was higher in females (5.9% vs 4.0%; OR 1.52, 95% CI 1.09-2.13, p = 0.014), and associated with diabetes (OR 1.97, CI 1.20-3.17, p = 0.005). History of antihypertension treatment appeared protective (OR 0.64, 95% CI 0.46-0.90, p = 0.009). RPD subtypes were dot in 18.5%, ribbon in 36.7%, and mixed in 36.3%. RPD were located outside the ETDRS grid in 88%, and most commonly in the outer superior subfield. Central grid involvement occurred in 12.1% of right and 14.3% of left eyes. RPD occurred in 25.9% of participants with grade 4 AMD in at least one eye. RPD was associated with visual dissatisfaction after controlling for age (OR 0.63, 95% CI 0.45-0.88, p = 0.007).
CONCLUSION: RPD occur more commonly than previously reported, most frequently in the upper-outer macular subfield, but also within the central subfield, albeit with reduced frequency and altered morphology. RPD may be associated with visual dissatisfaction and diabetes, but are less frequent in persons receiving antihypertension therapy.

Entities:  

Mesh:

Year:  2018        PMID: 29491487      PMCID: PMC5997694          DOI: 10.1038/s41433-018-0049-8

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  32 in total

1.  Clinical features of reticular pseudodrusen according to the fundus distribution.

Authors:  Mee Yon Lee; Jaemoon Yoon; Don-Il Ham
Journal:  Br J Ophthalmol       Date:  2012-07-06       Impact factor: 4.638

Review 2.  [Macular drusen].

Authors:  G Mimoun; G Soubrane; G Coscas
Journal:  J Fr Ophtalmol       Date:  1990       Impact factor: 0.818

3.  Smoking and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

Authors:  Jennifer S L Tan; Paul Mitchell; Annette Kifley; Victoria Flood; Wayne Smith; Jie Jin Wang
Journal:  Arch Ophthalmol       Date:  2007-08

4.  The Wisconsin age-related maculopathy grading system.

Authors:  R Klein; M D Davis; Y L Magli; P Segal; B E Klein; L Hubbard
Journal:  Ophthalmology       Date:  1991-07       Impact factor: 12.079

5.  Prevalence of age-related macular degeneration in an elderly UK Caucasian population-The Bridlington Eye Assessment Project: a cross-sectional study.

Authors:  C Wilde; A Poostchi; R L Mehta; H K MacNab; J G Hillman; S A Vernon; W M Amoaku
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775

6.  Reticular pseudodrusen. A risk factor in age-related maculopathy.

Authors:  J J Arnold; S H Sarks; M C Killingsworth; J P Sarks
Journal:  Retina       Date:  1995       Impact factor: 4.256

7.  Clinical characteristics of reticular pseudodrusen in Korean patients.

Authors:  Mee Yon Lee; Jaemoon Yoon; Don-Il Ham
Journal:  Am J Ophthalmol       Date:  2011-10-11       Impact factor: 5.258

8.  Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration.

Authors:  R Theodore Smith; Jackie K Chan; Mihai Busuoic; Vasuki Sivagnanavel; Alan C Bird; N Victor Chong
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-12       Impact factor: 4.799

9.  Localized reticular pseudodrusen and their topographic relation to choroidal watershed zones and changes in choroidal volumes.

Authors:  Florian Alten; Christoph R Clemens; Peter Heiduschka; Nicole Eter
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-07       Impact factor: 4.799

10.  Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model.

Authors:  Christine A Curcio; Jeffrey D Messinger; Kenneth R Sloan; Gerald McGwin; Nancy E Medeiros; Richard F Spaide
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

View more
  4 in total

1.  Complement factors and reticular pseudodrusen in intermediate age-related macular degeneration staged by multimodal imaging.

Authors:  Anne M Lynch; Alan G Palestine; Brandie D Wagner; Jennifer L Patnaik; Ashley A Frazier-Abel; Marc T Mathias; Frank S Siringo; Vernon Michael Holers; Naresh Mandava
Journal:  BMJ Open Ophthalmol       Date:  2020-01-14

2.  Natural course of adult-onset vitelliform lesions in eyes with and without comorbid subretinal drusenoid deposits.

Authors:  Craig Wilde; Mary Awad; Konstantinos Giannouladis; Arun Lakshmanan; Aaron Ming-Hon Yeung; Harminder Dua; Winfried M K Amoaku
Journal:  Int Ophthalmol       Date:  2020-03-04       Impact factor: 2.031

3.  Subretinal Drusenoid Deposit Formation: Insights From Turing Patterns.

Authors:  Benjamin K Young; Liangbo L Shen; Lucian V Del Priore
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.283

4.  Plasma Biomarkers of Reticular Pseudodrusen and the Risk of Progression to Advanced Age-Related Macular Degeneration.

Authors:  Anne M Lynch; Brandie D Wagner; Alan G Palestine; Nebojsa Janjic; Jennifer L Patnaik; Marc T Mathias; Frank S Siringo; Naresh Mandava
Journal:  Transl Vis Sci Technol       Date:  2020-09-11       Impact factor: 3.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.